STX — Shield Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Shield Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	4.14	2.94	16.3	3.4	13.9
Net Total Accounts Receivable
Net Total Receivables	1.15	0.656	4.73	4.51	11.2
Total Inventory
Prepaid Expenses
Total Current Assets	6.39	5.23	23.3	12.2	31.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.026	0.032	0.41	0.238	0.673
Net Intangible Assets
Total Assets	36.3	32.5	59.9	26.6	48.8
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.17	2.25	4.56	12.8	13.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	4.17	2.25	4.56	20.1	33.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	32.1	30.3	55.4	6.54	15
Total Liabilities & Shareholders' Equity	36.3	32.5	59.9	26.6	48.8
Total Common Shares Outstanding